LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | PF431396 | 0.37 | uM | LJP5 | 72 | hr | 765 | 1807 | 3124 | 0.5785 | 0.4419 |
Hs 578T | PF477736 | 0.37 | uM | LJP5 | 72 | hr | 765 | 797 | 3124 | 0.2552 | 0.0137 |
Hs 578T | PF562271 | 0.37 | uM | LJP6 | 72 | hr | 765 | 2251 | 3124 | 0.7205 | 0.6299 |
Hs 578T | PHA-665752 | 0.37 | uM | LJP5 | 72 | hr | 765 | 3114 | 3124 | 0.9967 | 0.9957 |
Hs 578T | PHA-793887 | 0.37 | uM | LJP6 | 72 | hr | 765 | 1113 | 3124 | 0.3564 | 0.1478 |
Hs 578T | PI103 | 0.37 | uM | LJP6 | 72 | hr | 765 | 968 | 3124 | 0.3099 | 0.0862 |
Hs 578T | PLX-4720 | 0.37 | uM | LJP5 | 72 | hr | 765 | 3751 | 3124 | 1.2006 | 1.2656 |
Hs 578T | QL-X-138 | 0.37 | uM | LJP6 | 72 | hr | 765 | 2050 | 3124 | 0.6563 | 0.5449 |
Hs 578T | QL-XII-47 | 0.37 | uM | LJP6 | 72 | hr | 765 | 2539 | 3124 | 0.8126 | 0.7518 |
Hs 578T | Radicicol | 0.37 | uM | LJP5 | 72 | hr | 765 | 2518 | 3124 | 0.8059 | 0.7429 |
Hs 578T | Radicicol | 0.37 | uM | LJP6 | 72 | hr | 765 | 2454 | 3124 | 0.7856 | 0.7161 |
Hs 578T | Seliciclib | 0.37 | uM | LJP5 | 72 | hr | 765 | 3110 | 3124 | 0.9955 | 0.9940 |
Hs 578T | Ruxolitinib | 0.37 | uM | LJP5 | 72 | hr | 765 | 3131 | 3124 | 1.0021 | 1.0027 |
Hs 578T | XL147 | 0.37 | uM | LJP5 | 72 | hr | 765 | 3091 | 3124 | 0.9894 | 0.9859 |
Hs 578T | Saracatinib | 0.37 | uM | LJP6 | 72 | hr | 765 | 2654 | 3124 | 0.8494 | 0.8006 |
Hs 578T | Selumetinib | 0.37 | uM | LJP6 | 72 | hr | 765 | 1601 | 3124 | 0.5125 | 0.3544 |
Hs 578T | Sirolimus | 0.37 | uM | LJP6 | 72 | hr | 765 | 1904 | 3124 | 0.6095 | 0.4829 |
Hs 578T | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 765 | 3768 | 3124 | 1.2059 | 1.2727 |
Hs 578T | SU11274 | 0.37 | uM | LJP5 | 72 | hr | 765 | 2978 | 3124 | 0.9531 | 0.9379 |
Hs 578T | Fedratinib | 0.37 | uM | LJP5 | 72 | hr | 765 | 2853 | 3124 | 0.9131 | 0.8849 |
Hs 578T | TGX221 | 0.37 | uM | LJP5 | 72 | hr | 765 | 2818 | 3124 | 0.9019 | 0.8701 |
Hs 578T | Torin1 | 0.37 | uM | LJP6 | 72 | hr | 765 | 867 | 3124 | 0.2777 | 0.0435 |
Hs 578T | Torin2 | 0.37 | uM | LJP5 | 72 | hr | 765 | 575 | 3124 | 0.1842 | -0.0803 |
Hs 578T | Tozasertib | 0.37 | uM | LJP5 | 72 | hr | 765 | 768 | 3124 | 0.2458 | 0.0013 |
Hs 578T | Trametinib | 0.37 | uM | LJP5 | 72 | hr | 765 | 1038 | 3124 | 0.3323 | 0.1158 |